Correlations of the changes in bioptic findings with echocardiographic, clinical and laboratory parameters in patients with inflammatory cardiomyopathy

Heart and Vessels

Volumn 31, Issue 3, 2016, Pages 416-426

  Krejci, Jan ^a,b   Hude, Petr ^a,b   Poloczkova, Hana ^a,b   Zampachova, Vita ^a,b   Stepanova, Radka ^a   Freiberger, Tomas ^c   Nemcova, Eva ^a,c   Spinarova, Lenka ^a,b  

^a ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

^c CENTRE FOR CARDIOVASCULAR SURGERY AND TRANSPLANTATION   (Czech Republic)

Author keywords

Echocardiography; Endomyocardial biopsy; Inflammatory cardiomyopathy; Left ventricular dysfunction; Myocarditis

Indexed keywords

ADULT; ARTICLE; CARDIOMYOPATHY; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE CLASSIFICATION; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BIOPSY; HUMAN; INFLAMMATORY CARDIOMYOPATHY; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONONUCLEAR CELL; MYOCARDITIS; PRIORITY JOURNAL; T LYMPHOCYTE; BIOPSY; BLOOD; CARDIAC MUSCLE; CARDIOMYOPATHIES; CONVALESCENCE; DIAGNOSTIC IMAGING; DOPPLER ECHOCARDIOGRAPHY; DRUG EFFECTS; HEART STROKE VOLUME; METABOLISM; MULTIVARIATE ANALYSIS; NEUTROPHIL CHEMOTAXIS; ODDS RATIO; PATHOLOGY; PREDICTIVE VALUE; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME;

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CARDIOVASCULAR AGENT; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADULT; BIOMARKERS; BIOPSY; CARDIOMYOPATHIES; CARDIOVASCULAR AGENTS; CHEMOTAXIS, LEUKOCYTE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDITIS; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; ODDS RATIO; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; RECOVERY OF FUNCTION; RISK FACTORS; STROKE VOLUME; T-LYMPHOCYTES; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84959546875     PISSN: 09108327     EISSN: 16152573     Source Type: Journal    
DOI: 10.1007/s00380-014-0618-0     Document Type: Article

References (53)

1. Stehlik J, Edwards LB, Kucheryavaya AY, Aurora P, Christie JD, Kirk R, Dobbels F, Rahmel AO, Hertz MI (2010) The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report-2010. J Heart Lung Transpl 29:1089–1103
2. Kühl U (2005) Antiviral treatment of myocarditis and acute dilated cardiomyopathy. Heart Fail Clin 1:559–587
3. Dennert R, Crijns HJ, Heymans S (2008) Acute viral myocarditis. Eur Heart J 29:2073–2082
4. Caforio A, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix S, Fu M, Helio T, Heymans S, Jahns R, Klingel K, Linhart A, Maisch B, McKenna W, Mogensen J, Pinto Y, Ristic A, Schultheiss H, Seggewiss H, Tavazzi L, Thiene G, Yilmaz A, Charron P, Elliott P (2013) Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 34:2636–2648
5. Basso C, Calabrese F, Corrado D, Thiene G (2001) Postmortem diagnosis in sudden cardiac death victims: macroscopic, microscopic and molecular findings. Cardiovasc Res 50:290–300
6. Wang H, Yao Q, Zhu S, Zhang G, Wang Z, Li Z, Sun R, Lu C, Li C, Pu J (2014) The autopsy study of 553 cases of sudden cardiac death in Chinese adults. Heart Vessels 29:486–495
7. Schultheiss HP, Kühl U, Cooper LT (2011) The management of myocarditis. Eur Heart J 32:2616–2625
8. Kindermann I, Barth C, Mahfoud F, Ukena C, Lenski M, Yilmaz A, Klingel K, Kandolf R, Sechtem U, Cooper LT, Böhm M (2012) Update on myocarditis. J Am Coll Cardiol 59:779–792
9. Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kühl U, Levine GN, Narula J, Starling RC, Towbin J, Virmani R (2007) The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation 116:2216–2233
10. Thiene G, Bruneval P, Veinot J, Leone O (2013) Diagnostic use of the endomyocardial biopsy: a consensus statement. Virchows Arch 463:1–5
11. Kühl U, Noutsias M, Seeberg B, Schultheiss HP (1996) Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy. Heart 75:295–300
12. Kindermann I, Kindermann M, Kandolf R, Klingel K, Bultmann B, Müller T, Lindinger A, Böhm M (2008) Predictors of outcome in patients with suspected myocarditis. Circulation 118:639–648
13. Krejci J, Poloczkova H, Hude P, Freiberger T, Nemcova E, Zampachova V, Sirotkova A, Stepanova R, Spinarova L, Nemec P, Vitovec J (2013) Impact of inflammatory infiltration and viral genome presence in myocardium on the changes of echocardiographic parameters. Cor et Vasa 55:e333–e340
14. D’Ambrosio A, Patti G, Manzoli A, Sinagra G, Di Lenarda A, Silvestri F, Di Sciascio G (2001) The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review. Heart 85:499–504
15. Cooper LT (2009) Myocarditis. N Eng J Med 360:1526–1538
16. Kühl U, Schultheiss HP (2012) Myocarditis. Dtsch Arztebl Int 109:361–368
17. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with Heart Failure Association (HFA) of the ESC. Eur Heart J 33:1787–1847
18. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL (2013) 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 128:e240–e327
19. Corsten MF, Schroen B, Heymans S (2012) Inflammation in viral myocarditis: friend or foe? Trends Mol Med 18:426–437
20. Caforio AL, Calabrese F, Angelini A, Tona F, Vinci A, Bottaro S, Ramondo A, Carturan E, Iliceto S, Thiene G, Daliento L (2007) A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J 28:1326–1333
21. Kühl U, Pauschinger M, Noutsias M, Seeberg B, Bock T, Lassner D, Poller W, Kandolf R, Schultheiss HP (2005) High prevalence of viral genomes and multiple viral infections in the myocardium of adults with “idiopathic” left ventricular dysfunction. Circulation 111:887–893
22. Wehlou C, Delanghe JR (2009) Detection of antibodies in cardiac autoimmmunity. Clin Chim Acta 408:114–122
23. Caforio AL, Mahon NJ, Tona F, McKenna WJ (2002) Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance. Eur J Heart Fail 4:411–417
24. Heymans S (2007) Myocarditis and heart failure? need for better diagnostic, predictive, and therapeutic tools. Eur Heart J 28:1279–1280
25. Rose NR (2009) Myocarditis: infection versus autoimmunity. J Clin Immunol 29:730–737
26. Mason JW (2003) Myocarditis and dilated cardiomyopathy: an inflammatory link. Cardiovasc Res 60:5–10
27. Stanton C, Mookadam F, Cha S, McNamara D, Aukrust P, Wojnicz R, Bailey K, Cooper L (2008) Greater symptom duration predicts response to immunomodulatory therapy in dilated cardiomyopathy. Int J Cardiol 128:38–41
28. McNamara DM, Holubkov R, Starling RC, Dec GW, Loh E, Torre-Amione G, Gass A, Janosko K, Tokarczyk T, Kessler P, Mann DL, Feldman AM (2001) Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation 103:2254–2259
29. Kato S, Morimoto S, Hiramitsu S, Uemura A, Ohtsuki M, Kato Y, Miyagishima K, Mori N, Hishida H (2007) Successful high-dose intravenous immunoglobulin therapy for patient with fulminant myocarditis. Heart Vessels 22:48–51
30. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, Glanowska G, Wilczewski P, Niklewski T, Zembala M, Polonski L, Rozek M, Wodniecki J, Frustaci A, Chimenti C (2001) Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation 104:39–45
31. Frustaci A, Russo MA, Chimenti C (2009) Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J 30:1995–2002
32. Frustaci A, Chimenti C, Calabrese F, Pieroni M, Thiene G, Maseri A (2003) Immunosuppressive therapy for active lymphocytic myocarditis. Virological and immunologic profile of responders versus nonresponders. Circulation 107:857–863
33. Maisch B, Bültman B, Factor S (1999) World Heart Federation consensus conference’s definition on inflammatory cardiomyopathy (myocarditis): report from two expert committees on histology and viral cardiomyopathy. Heartbeat 3:3–4
34. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellika PA, Picard HM, Roman MJ, Seward J, Shanwiese J, Solomon S, Spencer KT, St John Sutton M, Stewart W (2006) Recommendations for chamber quantification. Eur J Echocardiogr 7:79–108
35. Zimmermann O, Kochs M, Zwaka TP, Kaya Z, Lepper PM, Bienek-Ziolkowski M, Hoher M, Hornbach V, Torzewski J (2005) Myocardial biopsy based classification and treatment in patients with dilated cardiomyopathy. Int J Cardiol 104:92–100
36. McNamara DM, Starling RC, Cooper LT, Boehmer JP, Mather PJ, Janosko KM, Gorcsan J, Kip KE, Dec GW (2011) Clinical and demographic predictors of outcomes in recent onset dilated cardiomyopathy. J Am Coll Cardiol 58:1112–1118
37. McCarthy RE, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Hare JM, Baughman KL (2000) Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 342:690–695
38. Schultheiss HP, Kühl U (2009) What are the current treatment options for myocarditis? Dialogues Cardiovasc Med 14:187–193
39. Ishida K, Wada H, Sakakura K, Kubo N, Ikeda N, Sugawara Y, Ako J, Momomura S (2013) Long-term follow-up on cardiac function following fulminant myocarditis requiring percutaneous extracorporeal cardiopulmonary support. Heart Vessels 28:86–90
40. Blauwet LA, Cooper LT (2010) Myocarditis. Prog Cardiovasc Dis 52:274–288
41. Heymans S, Hirsch E, Anker SD, Aukrust P, Balligand JL, Cohen-Tervaert JW, Drexler H, Filippatos G, Felix SB, Gullestad L, Hilfiker-Kleiner D, Janssens S, Latini R, Neubauer G, Paulus WJ, Pieske B, Ponikowski P, Schroen B, Schultheiss HP, Tschöpe C, Van Bilsen M, Zannad F, McMurray J, Shah AM (2009) Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 11:119–129
42. Mendes LA, Dec GW, Picard MH, Palacios IF, Newell J, Davidoff R (1994) Right ventricular dysfunction: an independent predictor of adverse outcome in patients with myocarditis. Am Heart J 128:301–307
43. Bleasdale RA, Frenneaux MP (2002) Prognostic importance of right ventricular dysfunction. Heart 88:323–324
44. Meluzin J, Spinarova L, Dusek L, Toman J, Hude P, Krejci J (2003) Prognostic importance of the right ventricular function assessed by Doppler tissue imaging. Eur J Echocardiogr 4:262–271
45. Voelkel NF, Quaife RA, Leinwand LA, Barst RJ, McGoon MD, Meldrum D, Dupuis J, Long CS, Rubin LJ, Smart FW, Suzuki YJ, Gladwin M, Denholm EM, Gail DB (2006) Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation 114:1883–1891
46. Mahrholdt H, Wagner A, Deluigi CC, Kispert E, Hager S, Meinhardt G, Vogelsberg H, Fritz P, Dippon J, Bock CT, Klingel K, Kandolf R, Sechtem U (2006) Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 114:1581–1590
47. Bossone E, Shea MJ, Niclas JM, Abrams GD, Das SK (2000) Early spontaneous recovery of left ventricular function in patients with myocarditis. Ital Heart J 1:758–761
48. Bahk TJ, Daniels MD, Leon JS, Wang K, Engman DM (2008) Comparison of angiotension converting enzyme inhibition and angiotension II receptor blocade for prevention of experimental autoimmune myocarditis. Int J Cardiol 125:85–93
49. Saegusa S, Fei Y, Takahashi T, Sumino H, Moriya J, Kawaura K, Yamakawa J, Itoh T, Morimoto S, Nakahashi T, Iwai K, Matsumoto M, Kanda T (2007) Oral administration of candesartan improves the survival of mice with viral myocarditis through modification of cardiac adiponectin expression. Cardiovasc Drug Ther 21:155–160
50. Fujita S, Shimojo N, Terasaki F, Otsuka K, Hosotani N, Kohda Y, Tanaka T, Nishioka T, Yoshida T, Hiroe M, Kitaura Y, Ishizaka N, Imanaka-Yoshida K (2013) Atrial natriuretic peptide exerts protective action against angiotensin II-induced cardiac remodelling by attenuating inflammation via endothelin-1/endothelin receptor A cascade. Heart Vessels 28:646–657
51. Yuan Z, Shioji K, Kihara Y, Takenada H, Onozawa Y, Kishimoto C (2004) Cardioprotective effect of carvedilol on acute autoimmune myocarditis: antiinflammatory effects associated with antioxydant property. Am J Physiol Heart Circ Physiol 286:H83–H90
52. Pauschinger M, Rutschow S, Chandrasekharan K, Westermann D, Weitz A, Peter Schwimmbeck L, Zeichhardt H, Poller W, Noutsias M, Li J, Schultheiss H, Tschope C (2005) Carvedilol improves left ventricular function in murine coxsackievirus-induced acute myocarditis association with reduced myocardial interleukin-1beta and MMP-8 expression and a modulated immune response. Eur J Heart Fail 7:444–452
53. Xiao J, Shimada M, Liu W, Hu D, Matsumori A (2009) Antiinflammatory effect of eplerenone on viral myocarditis. Eur J Heart Fail 11:349–353